Alnylam Pharmaceuticals, Inc.
Compositions and Methods for Inhibition of Expression of Apolipoprotein C-III (APOC3) Genes
Last updated:
Abstract:
The invention relates to double-stranded ribonucleic acid (dsRNA) targeting an APOC3 gene, and methods of using the dsRNA to inhibit expression of APOC3.
Status:
Application
Type:
Utility
Filling date:
2 Dec 2019
Issue date:
20 Aug 2020